The task force reasons that if the average life expectancy of a 75-year-old-man is 10 years, a slow-growing cancer like this one is unlikely to affect his lifespan, and as a result there is no benefit to screening.
For younger men, the task force advises discussing the PSA test with a doctor before screening.
But not all health officials agree with the new guidelines and say screening should be based on an individuals health history and personal risk factors.